The method lets researchers identify and control larger numbers of atomic-scale defects, to build a bigger system of qubits.

Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.

State-of-the-art toolset will bridge academic innovations and industry pathways to scale for semiconductors, microelectronics, and other critical technologies.

Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.

High-speed experiments can help identify lightweight, protective “metamaterials” for spacecraft, vehicles, helmets, or other objects.

The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.

MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.

Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.

The one-step fabrication process rapidly produces miniature chemical reactors that could be used to detect diseases or analyze substances.

The advance opens a path to next-generation devices with unique optical and electronic properties.